Research output

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Research output: Contribution to journalReview articleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • PHASE-III TRIAL, WEEKLY PACLITAXEL, VINFLUNINE PLUS, SUPPORTIVE CARE, OPEN-LABEL, CARCINOMA, MONOTHERAPY, MULTICENTER, DOCETAXEL
View graph of relations

Details

Original languageEnglish
Pages (from-to)655-667
Number of pages13
JournalPharmacoeconomics
Volume37
Issue number5
DOIs
Publication statusPublished - May 2019